The average value of Bcl-6 mRNA in healthy controls, CML-CP and CML-BP patients was (0.10±0.02), (0.83±0.03), (0.86 ±0.04), respectively (Figure 5B). This evidence concerns the gene BCL6 and chronic myelogenous leukemia, BCR-ABL1 positive.